Hematopoietic Stem Cell Transplant for Pediatric Acute Promyelocytic Leukemia

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 7, 2008, Pages 824-830

  Dvorak, Christopher C ^a   Agarwal, Rajni ^b   Dahl, Gary V ^b   Gregory, John J ^c   Feusner, James H ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Atlantic Health   (United States)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

Acute promyelocytic leukemia; Allogeneic transplantation; Autologous transplantation; Pediatric

Indexed keywords

ARSENIC TRIOXIDE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; IDARUBICIN; MERCAPTOPURINE; METHOTREXATE; RETINOIC ACID; STEROID; TACROLIMUS; THIOTEPA;

ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RESISTANCE; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; LEUKEMIA RELAPSE; MALE; MONOTHERAPY; OVERALL SURVIVAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 44649086984     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.04.015     Document Type: Article

References (29)

1. Gregory J., and Feusner J. Acute promyelocytic leukaemia in children. Best Pract Res Clin Haematol 16 (2003) 483-494
2. Mann G., Reinhardt D., Ritter J., et al. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children. Ann Hematol 80 (2001) 417-422
3. de Botton S., Coiteux V., Chevret S., et al. Outcome of childhood acute promyelocytic leukemia with all-trans retinoic acid and chemotherapy. J Clin Oncol 22 (2004) 1404-1412
4. Ortega J.J., Madero L., Martín G., et al. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group. J Clin Oncol 23 (2005) 7632-7640
5. Testi A.M., Biondi A., Lo Coco F., et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. Blood 106 (2005) 447-453
6. Gregory J., Kim H., Alonzo T., et al. Phase III trial of all-trans retinoic acid (ATRA) vs daunorubicin (D) and cytosine arabinoside (A) as induction therapy and ATRA vs observation as maintenance therapy for children with newly diagnosed acute promyelocytic leukemia (APL). ASH Ann Meet Abstr 106 (2005) 894
7. Grimwade D., Jamal R., Goulden N., Kempski H., Mastrangelo S., and Veys P. Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acid. Br J Haematol 103 (1998) 559-562
8. Visani G., Buonamici S., Malagola M., et al. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study. Leukemia 15 (2001) 1696-1700
9. Ferrara F., Selleri C., Mele G., et al. Late relapse of acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy: report of two cases. Ann Hematol 83 (2004) 484-486
10. de Botton S., Fawaz A., Chevret S., et al. Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group. J Clin Oncol 23 (2005) 120-126
11. Roman J., Martin C., and Torres A. Absence of detectable PML-RARa fusion transcripts in long-term remission patients after BMT for acute promyelocytic leukemia. Bone Marrow Transplant 19 (1997) 679-683
12. Sanz M.A., Labopin M., Gorin N.C., et al. Hematopoietic stem cell transplantation for adults with acute promyelocytic leukemia in the ATRA era: a survey of the European Cooperative Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39 (2007) 461-469
13. Thomas X., Dombret H., Cordonnier C., et al. Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Leukemia 14 (2000) 1006-1013
14. Meloni G., Diverio D., Vignetti M., et al. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcriptase polymerase chain reaction of the PML/RARa fusion gene. Blood 90 (1997) 1321-1325
15. Lo-Coco F., Romano A., Mengarelli A., et al. Allogeneic stem cell transplantation for advanced acute promyelocytic leukemia: results in patients treated in second molecular remission or with molecularly persistent disease. Leukemia 17 (2003) 1930-1933
16. Bourquin J., Thornley I., Neuberg D., et al. Favorable outcome of allogeneic hematopoietic stem cell transplantation for relapsed or refractory acute promyelocytic leukemia in childhood. Bone Marrow Transplant 34 (2004) 795-798
17. Dvorak C., Sanders R., Dahl G., Donaldson S., and Razzouk B. Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose antimetabolite-based chemotherapy. Pediatr Blood Cancer 48 (2007) 582-585
18. Tallman M., Andersen J., Schiffer C., et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 100 (2002) 4298-4302
19. Tallman M.S., Andersen J.W., Schiffer C.A., et al. All-trans-retinoic acid in acute promyelocytic leukemia. N Engl J Med 337 (1997) 1021-1028
20. Powell B., Moser B., Stock W., and Feusner J. Effect of consolidation with arsenic trioxide (As2O3) on event-free survival (EFS) and overall survival (OS) among patients with newly diagnosed acute promyelocytic leukemia (APL): North American intergroup protocol C9710 (abstract). J Clin Oncol 25 (2007) 2
21. Capria S., Latagliata R., Avvisati G., et al. BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results. Bone Marrow Transplant 36 (2005) 83-84
22. Sanz M.A., Lo Coco F., Martín G., et al. Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96 (2000) 1247-1253
23. Thomas X., Le Q., de Botton S., et al. Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy. Leuk Lymphoma 46 (2005) 1007-1016
24. Aladjidi N., Auvrignon A., Leblanc T., et al. Outcome in children with relapsed acute myeloid leukemia after initial treatment with the French Leucemie Aique Myeloide Enfant (LAME) 89/91 protocol of the French society of pediatric hematology and immunology. J Clin Oncol 21 (2003) 4377-4385
25. Vignetti M., Rondelli R., Locatelli F., et al. Autologous bone marrow transplantation in children with acute myeloblastic leukemia: report from the Italian National Pediatric Registry (AIEOP-BMT). Bone Marrow Transplant 18 Suppl 2 (1996) 59-62
26. Nemecek E.R., Gooley T.A., Woolfrey A.E., Carpenter P.A., Matthews D.C., and Sanders J.E. Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemia. Bone Marrow Transplant 34 (2004) 799-806
27. Gambacorti-Passerini C., Grignani F., Arienti F., Pandolfi P.P., Pelicci P.G., and Parmiani G. Human CD4 lymphocytes specifically recognize a peptide representing the fusion region of the hybrid protein pml/RAR alpha present in acute promyelocytic leukemia cells. Blood 81 (1993) 1369-1375
28. Ozdemir E., and Molldrem J.J. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia. Bone Marrow Transplant 37 (2006) 785-786
29. Wadleigh M., Richardson P., Zahrieh D., et al. Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation. Blood 102 (2003) 1578-1582